VALANX Biotech
Company Details
Status: Private
Employees: 11-50
Location:
17 elisabethgasse, klosterneuburg, lower austria, austria
Type:
sample
sample
Technology:
sample
About: VALANX Biotech is a biotechnology company based in Graz, Austria, founded in 2017 as a spin-off from Graz University of Technology. The company specializes in site-specific protein conjugation, focusing on advancing biologics development through synthetic biology and genetic code expansion. VALANX operates additional lab facilities at the Vienna Biocenter.
The company offers a patented protein conjugation platform that allows precise control over conjugation sites and modifications on target proteins. This technology incorporates non-natural amino acids, enabling the development of protein-drug conjugates, diagnostics, and biocatalysis products. VALANX aims to create biologics for therapeutic and diagnostic applications, particularly in cancer drug targeting, with the capability of up to 10 selectable conjugation sites per protein. The company collaborates with partners to enhance reproducibility and cost efficiency in conjugate development and has raised $2.56 million in funding.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
VALANX Biotech | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.